• Unilever Plc: DZ Bank AG Research upgrades to buy from hold with a price target reduced from GBP 51.75 to GBP 51.50.
  • Melrose Industries Plc: RBC Capital maintains its outperform rating and raises the target price from GBX 650 to GBX 760.
  • Standard Chartered Plc: Mediobanca maintains its underperform recommendation with a price target raised from 860 to GBX 910.
  • M&G Plc: Deutsche Bank maintains its hold recommendation with a price target reduced from GBX 230 to GBX 225.
  • Glencore Plc: Barclays maintains its overweight recommendation and reduces the target price from 4.85 to GBP 4.60.
  • 3I Group Plc: Morgan Stanley maintains its overweight recommendation and raises the target price from GBX 4069 to GBX 4940.
  • Mondi Plc: JP Morgan maintains its neutral recommendation and reduces the target price from 14.80 to GBP 13.90.
  • Centrica Plc: Jefferies maintains its buy recommendation and raises the target price from GBX 150 to GBX 180.
  • Bath & Body Works, Inc.: Barclays upgrades to equalweight from underweight with a price target raised from USD 34 to USD 43.
  • Boyd Gaming Corporation: Morgan Stanley downgrades to equalwt from overwt with a target price reduced from USD 82 to USD 81.
  • Floor & Decor Holdings, Inc.: Stifel upgrades to buy from hold with a target price raised from USD 100 to USD 110.
  • Nike, Inc.: Jefferies upgrades to buy from hold with a price target raised from USD 75 to USD 115.
  • Old Dominion Freight Line, Inc.: Stifel upgrades to buy from hold with a price target raised from USD 193 to USD 200.
  • Roku, Inc.: Baptista Research downgrades to underperform from hold with a target price reduced from USD 82 to USD 79.20.
  • Tesla, Inc.: Mirae Asset Securities upgrades to accumulate from buy with a target price reduced from USD 394 to USD 390.
  • Twilio Inc.: Morgan Stanley upgrades to overweight from equal weight with a target price raised from USD 144 to USD 160.
  • Xpo, Inc.: Stifel upgrades to buy from hold with a target price of USD 147.
  • Celanese Corporation: Barclays maintains its equalweight recommendation and reduces the target price from USD 75 to USD 59.